NCT06111885View on ClinicalTrials.gov

Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention

PHASE2RecruitingINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Kidney Stone
Interventions
DRUG

Indapamide 2.5 MG

1 indapamide 2.5 mg capsule per day for 28 days

DRUG

Hydrochlorothiazide 50Mg

1 hydrochlorothiazide 50 mg capsule per day for 28 days

DRUG

Chlorthalidone 25mg

1 chlorthalidone 25 mg capsule per day for 28 days

Trial Locations (1)

3010

RECRUITING

Inselspital, Department of Nephrology and Hypertension, Bern

All Listed Sponsors
collaborator

Department of clinical research, Bern

UNKNOWN

lead

Insel Gruppe AG, University Hospital Bern

OTHER